CBD: no risk to public health or abuse according to WHO
Consumption of the cannabidiol (CBD), a cannabinoid naturally produced by cannabis, is safe, well tolerated, and poses no risk to public health, according to the preliminary report of the World Health Organization (WHO) Expert Committee on Drug Dependence.
The authors of the report also state that CBD «has no potential for abuse» and does not lead to physical dependence. «CBD is generally well tolerated and has a good safety profile.».
Concerning therapeutic effects of CBD, the WHO reports that it «has been shown to be an effective treatment for epilepsy» and that there is «preliminary evidence that CBD may be a useful treatment for a number of other conditions,» including Alzheimer’s, cancer, Parkinson’s disease, and psychosis.
While the report notes that «unregulated medical use of CBD» in oils or extracts is relatively common, it states that «there is no evidence of recreational use of CBD or of health problems associated with the use of pure CBD.»
The WHO is currently considering investing in CBD on international lists of controlled substances. Following the review, which is expected to take place in May 2018, the use of CBD could be restricted—as THC is today—and limited to the medical sector.
The British medical cannabis market is expected to exceed 140,000 patients by 2026
«Support. Don’t Punish 2026»: A Global Call to Replace Repression with Public Health Measures
St. Gallen, Switzerland, Launches Its 7th Legal Cannabis Pilot Project
The Irish Parliament recommends decriminalizing all drugs
Reunion Island: The CBD Cannabis Cup Returns to Jardin Maniron on August 16, 2026
The U.S. cannabis industry reports its first job loss
Why Les Frères CBD Has Established Itself as a Trusted Leader
Medical cannabis cultivation officially begins in Nebraska
"We All Pay the Price of Drugs": A New Campaign to Reposition the Fight Against Drug Trafficking
Uruguay Wants to Integrate Medical Cannabis into Its Healthcare System
-
Cannabis in Africa3 weeks agoNigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France4 weeks ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Business3 weeks ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in France4 weeks ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean4 weeks ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Business3 weeks ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Business2 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabinoids4 weeks ago
Japan bans CBN
You must be logged in to post a comment Login